ArticleCancers2020

A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells.

Abel Soto-Gamez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.